Literature DB >> 9111056

Biosynthesis of the type I and type II TGF-beta receptors. Implications for complex formation.

R G Wells1, H Yankelev, H Y Lin, H F Lodish.   

Abstract

The TGF-beta type I and type II receptors (TbetaRI and TbetaRII) are signaling receptors that form heteromeric cell surface complexes with the TGF-betas as one of the earliest events in the cellular response to these multifunctional growth factors. Using TGF-beta-responsive mink lung epithelial cells (Mv1Lu), we have determined the half-lives of the endoplasmic reticulum (ER) and mature forms of these receptors. In metabolically labeled cells, approximately 90% of newly synthesized type II receptor undergoes modification of N-linked sugars in the Golgi, with a half-life of 30-35 min; the Golgi-processed form of the receptor has a relatively short metabolic half-life of 2.5 h. In contrast, only 50% of pulse-labeled type I receptor is converted to the Golgi-processed and therefore endoglycosidase H-resistant form, and the endoglycosidase H-sensitive ER form has a half-life of 2.8-3 h. Addition of 100 pM TGF-beta1 causes the Golgi-processed type II receptor to become less stable, with a half-life of 1.7 h, and also destabilizes the Golgi-processed type I receptor. TGF-beta1 binding and cross-linking experiments on cells treated with tunicamycin for various times confirm different ER to cell surface processing times for TbetaRI and TbetaRII. Our results, which suggest that stable complexes between type I and II TGF-beta receptors do not form until the proteins reach a post-ER compartment (presumably the cell surface), have important implications for our understanding of complex formation and receptor regulation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9111056     DOI: 10.1074/jbc.272.17.11444

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  Responsiveness to transforming growth factor-beta (TGF-beta)-mediated growth inhibition is a function of membrane-bound TGF-beta type II receptor in human breast cancer cells.

Authors:  M A Lynch; T A Petrel; H Song; T J Knobloch; B C Casto; D Ramljak; L M Anderson; V DeGroff; G D Stoner; R W Brueggemeier; C M Weghorst
Journal:  Gene Expr       Date:  2001

Review 2.  Specificity, versatility, and control of TGF-β family signaling.

Authors:  Rik Derynck; Erine H Budi
Journal:  Sci Signal       Date:  2019-02-26       Impact factor: 8.192

3.  Differential molecular regulation of processing and membrane expression of Type-I BMP receptors: implications for signaling.

Authors:  Tal Hirschhorn; Michal Levi-Hofman; Oded Danziger; Nechama I Smorodinsky; Marcelo Ehrlich
Journal:  Cell Mol Life Sci       Date:  2017-03-29       Impact factor: 9.261

4.  Type III TGF-beta receptor-independent signalling of TGF-beta2 via TbetaRII-B, an alternatively spliced TGF-beta type II receptor.

Authors:  D Rotzer; M Roth; M Lutz; D Lindemann; W Sebald; P Knaus
Journal:  EMBO J       Date:  2001-02-01       Impact factor: 11.598

Review 5.  The TGF-β Family in Caenorhabditis elegans.

Authors:  Cathy Savage-Dunn; Richard W Padgett
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-06-01       Impact factor: 10.005

6.  Binding and biologic characterization of recombinant human serum albumin-eTGFBR2 fusion protein expressed in CHO cells.

Authors:  Aini Wan; Yana Miao; Lin Peng; Yanfei Cai; Yun Chen; Yang He; Jianfeng Yang; Jian Jin; Huazhong Li
Journal:  Bioengineered       Date:  2017-02-17       Impact factor: 3.269

7.  BMP signaling requires retromer-dependent recycling of the type I receptor.

Authors:  Ryan J Gleason; Adenrele M Akintobi; Barth D Grant; Richard W Padgett
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-03       Impact factor: 11.205

8.  Deletion of Tgfbr2 in Prx1-cre expressing mesenchyme results in defects in development of the long bones and joints.

Authors:  Hwa-Seon Seo; Rosa Serra
Journal:  Dev Biol       Date:  2007-08-09       Impact factor: 3.582

9.  Transforming growth factor beta1 receptor II is downregulated by E1A in adenovirus-infected cells.

Authors:  Vera L Tarakanova; William S M Wold
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

10.  TGF-beta binding in human Wharton's jelly.

Authors:  Andrzej Małkowski; Krzysztof Sobolewski; Stefan Jaworski; Edward Bańkowski
Journal:  Mol Cell Biochem       Date:  2008-01-24       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.